5.3.6 CUMULATIVE ANALYSIS OF POST-AUTHORIZATION ADVERSE EVENT REPORTS OF PF-07302048 (BNT162B2) RECEIVED THROUGH 28-FEB-2021

Pfizer early post-authorization adverse event report – Feb 2021. Concealed by FDA until released months later under order of court. Multiple serious adverse events reported, including 1223 deaths, 87.5% abortions/neonatal deaths (28/32), and . 9-Page appendix with list of adverse events of special interest (AESI).